Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Neal Walker currently holds 190,425 shares of Aclaris Therapeutics, Inc. (ACRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neal Walker has been a net seller of ACRS stock. They have purchased $217.5K and sold $5.4M worth of shares.
Neal Walker's most recent insider trade was on Feb 3, 2026, when they sold 63,475 shares at $0.00 per share.
Neal Walker serves as Executive at Aclaris Therapeutics, Inc. (ACRS). They have executed 106 insider transactions totaling $5.6M over their tenure at the company.
Neal Walker holds the position of Executive at Aclaris Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Neal Walker has shown a selling trading pattern, with $217.5K in total purchases and $5.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Neal Walker was on Feb 1, 2023, when they sold $418.8K worth of ACRS shares. This transaction involved 25,000 shares at $16.75 per share.
Neal Walker currently owns 190,425 shares of Aclaris Therapeutics, Inc. (ACRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Neal Walker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Neal Walker has 106 Form 4 filings on record as an insider at Aclaris Therapeutics, Inc..
Set alerts for Neal Walker and 40,000+ other insiders.